EMAIL THIS PAGE TO A FRIEND

BMC complementary and alternative medicine

Pro-apoptotic and anti-adhesive effects of four African plant extracts on the breast cancer cell line MCF-7.


PMID 25199565

Abstract

Jatropha curcas (JCP1), Pyrenacantha staudtii (PS), Picralima nitida (ZI) and Jatropha gossypifolia (JCP2) are plants used in the African folklore for the treatment of various cancers. This study investigated the in vitro anticancer effects of the ethanol extracts against human epithelial MCF-7 breast cancer cells in a dose-dependent manner (1-50 μg/ml) by using cell cycle analysis, viability assay, annexin V/PI staining, TUNEL method and expression determination of apoptotic and adhesion relevant proteins. Adhesion processes were monitored by detachment via flow cytometry, β1-integrin expression and formation of the actin cytoskeleton. The three extracts, termed PS, JCP1 and JCP2 at a concentration of 10 μg/ml induced cell death in MCF-7 breast cancer cells verified by high amounts of PI-positive cells in the cell cycle analysis, Annexin V/PI staining and DNA fragmentation measurements. In parallel cell detachment was accompanied by decreased β1- integrin expression and phosphorylation of the focal adhesion kinase at Tyr397. ZI extract was the exception by the increasing β1-integrin expression and strengthening the cortical actin cytoskeleton. However, all four plant extracts mediated strong anti-cancer properties with IC50 values between 23-38 μg/ml. PS, JCP1 and JCP2 were found to be very active against MCF-7 cells by inducing anoikis and therefore possessing vast potential as medicinal drugs especially in estrogen receptor positive breast cancer treatment. ZI mediated their anti-cancer action by different signaling mechanisms which should be analyzed in future studies. Our results further supported the idea that medicinal plants can be promising sources of putative anticancer agents.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300665
Anti-FAK (Ab-397) antibody produced in rabbit, affinity isolated antibody
SAB4502495
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502496
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502498
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502499
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4502503
Anti-FAK antibody produced in rabbit, affinity isolated antibody
SAB4300597
Anti-PTK2 (Ab-576/577) antibody produced in rabbit, affinity isolated antibody
SAB4300355
Anti-PTK2 (Ab-861) antibody produced in rabbit, affinity isolated antibody
SAB4300418
Anti-PTK2 (Ab-925) antibody produced in rabbit, affinity isolated antibody
SAB1412655
ANTI-PTK2 antibody produced in mouse, clone 1D7, purified immunoglobulin, buffered aqueous solution
WH0005747M1
Monoclonal Anti-PTK2 antibody produced in mouse, clone 2C3, purified immunoglobulin, buffered aqueous solution
SAB1404275
Monoclonal Anti-PTK2 antibody produced in mouse, clone 1C1, purified immunoglobulin, buffered aqueous solution
SAB5300395
Monoclonal Anti-PTK2 antibody produced in mouse, clone 4A9D6, ascites fluid
SAB5300396
Monoclonal Anti-PTK2 antibody produced in mouse, clone 10H7A6, purified immunoglobulin, buffered aqueous solution
SAB5300397
Monoclonal Anti-PTK2 antibody produced in mouse, clone 10H7E9, ascites fluid
SAB5300398
Monoclonal Anti-PTK2 antibody produced in mouse, clone 10H7, ascites fluid